Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Clinical Study on Material Balance of [14C]Zorifertinib in Healthy Adult Male Participants in China

NCT07620951 is registered in ClinicalTrials.gov with Alpha Biopharma (Jiangsu) Co., Ltd. as lead sponsor.

NCT NCT07620951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07620951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Clinical Study on Material Balance of [14C]Zorifertinib in Healthy Adult Male Participants in China
Lead sponsor
Alpha Biopharma (Jiangsu) Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
July 6, 2026
Completion date
August 3, 2026
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central nervous system (cns) metastases, egfr mutant advanced non-small cell lung cancer